GlassScriptPhysician profile
Jennifer Kuo
NPI 1730534074
$34,265.87
in general payments reported to CMS, 2019-2025
24 companies · $8.12 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30K · 2022: $132 · 2023: $3,652 · 2024: $317 · 2025: $8.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $976.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $30,187.22 | 2021-2022 | |
| Intuitive Surgical, INC. | $3,000.00 | 2023 | Davinci Xi |
| Medtronic, INC. | $149.23 | 2023 | Interstim |
| Sumitomo Pharma America, INC. | $108.46 | 2023-2024 | Orgovyx |
| Coloplast Corp | $85.94 | 2023-2024 | Speedicath |
| Urogen Pharma, INC. | $85.31 | 2023-2024 | Jelmyto |
| Myriad Genetic Laboratories, INC. | $82.47 | 2023 | Prolaris |
| 180 Medical, INC. | $69.97 | 2022-2024 | Gentlecath |
| Abbvie INC. | $64.47 | 2023-2024 | |
| Axonics, INC. | $60.36 | 2023-2024 | Axonics |
| Endo Pharmaceuticals INC. | $53.87 | 2023-2024 | Xiaflex |
| Cook Medical LLC | $42.92 | 2021 | |
| Caldera Medical, INC | $42.14 | 2023 | Desara |
| Halozyme INC | $36.81 | 2023 | |
| Merck Sharp & Dohme LLC | $26.67 | 2024 | Keytruda, Welireg |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $26.21 | 2022-2023 | Itind System |
| Dendreon Pharmaceuticals LLC | $25.19 | 2023 | Provenge |
| Tempus Ai, INC | $22.24 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.90 | 2023 | |
| Urovant Sciences INC | $20.50 | 2022 | |
| Photocure INC | $17.13 | 2024 | Cysview |
| Astrazeneca Pharmaceuticals LP | $16.83 | 2024 | Lynparza |
| Antares Pharma, INC. | $11.91 | 2022 | |
| Laborie Medical Technologies Corp. | $8.12 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Kuo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.